TORSADE-DE-POINTES AFTER INHALED PENTAMIDINE

被引:9
作者
ENGRAV, MB
COODLEY, G
MAGNUSSON, AR
机构
[1] Oregon Health Sciences University, Portland
关键词
PENTAMIDINE; TORSADE DE POINTES;
D O I
10.1016/S0196-0644(05)81912-2
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
The case of a 40-year-old HIV-positive man who had multiple episodes of torsade de pointes is presented. The patient's history was pertinent for the use of inhaled pentamidine the day before admission. His episodes of torsade de pointes were refractory to the usual therapy. His presentation, laboratory work, echocardiography, computed tomography scan, and treatment are reviewed. Physicians should be aware of the association of pentamidine with torsade de pointes.
引用
收藏
页码:1403 / 1405
页数:3
相关论文
共 21 条
[1]
Mitchell, Dodek, Lawson, Et al., Torsade de pointes during intravenous pentamidine isethionate therapy, Can Med Assoc J, 140, pp. 173-174, (1989)
[2]
Wharton, Demopulos, Goldschlager, Torsade de pointes during administration of pentamidine isethionate, Am J Med, 83, pp. 571-576, (1987)
[3]
Green, Reents, Harman, Et al., Pentamidine-induced torsade de pointes in a renal transplant recipient with Pneumocystis carinii pneumonia, South Med J, 4, pp. 81-84, (1983)
[4]
Hancock, Possible torsade in a patient with AIDS, Hosp Pract, 25, pp. 132-134, (1990)
[5]
Wilson, Braunwald, Isselbacker, Et al., Harrison's Principles of Internal Medicine, (1987)
[6]
Sasynuiuk, Valois, Toy, Recent advances in understanding the mechanisms of drug-induced torsade de pointes arrhythmias, The American Journal of Cardiology, 64, pp. 29J-32J, (1989)
[7]
Brugada, Torsade de pointes, PACE, 11, pp. 2246-2249, (1988)
[8]
Monk, Benefield, Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia, Drugs, 39, pp. 741-756, (1990)
[9]
Western, Penera, Schultz, Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia, Ann Intern Med, 73, pp. 695-702, (1970)
[10]
Conte, Golden, Concentrations of aerosolized pentamidine in bronchoalveolar lavage, systemic absorption, and excretion, Antimicrob Agents Chemother, 32, pp. 1490-1493, (1988)